Cargando…

Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy

Lupus panniculitis is a rare manifestation of cutaneous lupus erythematosus, which may lead to major aesthetic sequelae with a severe impact on patients’ quality of life. We report 2 cases supporting the short- and long-term efficacy and safety of lipofilling in the treatment of lupus panniculitis-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Polivka, Laura, Revol, Marc, Battistella, Maxime, Bachelez, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126595/
https://www.ncbi.nlm.nih.gov/pubmed/27920685
http://dx.doi.org/10.1159/000452325
_version_ 1782470130018549760
author Polivka, Laura
Revol, Marc
Battistella, Maxime
Bachelez, Hervé
author_facet Polivka, Laura
Revol, Marc
Battistella, Maxime
Bachelez, Hervé
author_sort Polivka, Laura
collection PubMed
description Lupus panniculitis is a rare manifestation of cutaneous lupus erythematosus, which may lead to major aesthetic sequelae with a severe impact on patients’ quality of life. We report 2 cases supporting the short- and long-term efficacy and safety of lipofilling in the treatment of lupus panniculitis-induced atrophy. These observations pave the way for prospective, larger-scale studies in patients with scarring lupus panniculitis, provided that the autoimmune pathogenic process is in complete, stable remission.
format Online
Article
Text
id pubmed-5126595
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-51265952016-12-05 Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy Polivka, Laura Revol, Marc Battistella, Maxime Bachelez, Hervé Case Rep Dermatol Case Series Lupus panniculitis is a rare manifestation of cutaneous lupus erythematosus, which may lead to major aesthetic sequelae with a severe impact on patients’ quality of life. We report 2 cases supporting the short- and long-term efficacy and safety of lipofilling in the treatment of lupus panniculitis-induced atrophy. These observations pave the way for prospective, larger-scale studies in patients with scarring lupus panniculitis, provided that the autoimmune pathogenic process is in complete, stable remission. S. Karger AG 2016-11-15 /pmc/articles/PMC5126595/ /pubmed/27920685 http://dx.doi.org/10.1159/000452325 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Series
Polivka, Laura
Revol, Marc
Battistella, Maxime
Bachelez, Hervé
Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy
title Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy
title_full Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy
title_fullStr Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy
title_full_unstemmed Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy
title_short Lipofilling: A New Therapeutic Option for the Treatment of Lupus Panniculitis-Induced Atrophy
title_sort lipofilling: a new therapeutic option for the treatment of lupus panniculitis-induced atrophy
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126595/
https://www.ncbi.nlm.nih.gov/pubmed/27920685
http://dx.doi.org/10.1159/000452325
work_keys_str_mv AT polivkalaura lipofillinganewtherapeuticoptionforthetreatmentoflupuspanniculitisinducedatrophy
AT revolmarc lipofillinganewtherapeuticoptionforthetreatmentoflupuspanniculitisinducedatrophy
AT battistellamaxime lipofillinganewtherapeuticoptionforthetreatmentoflupuspanniculitisinducedatrophy
AT bachelezherve lipofillinganewtherapeuticoptionforthetreatmentoflupuspanniculitisinducedatrophy